208 related articles for article (PubMed ID: 31970786)
1. Expression and clinicopathological significance of lipin-1 in human breast cancer and its association with p53 tumor suppressor gene.
Dinarvand N; Khanahmad H; Hakimian SM; Sheikhi A; Rashidi B; Bakhtiari H; Pourfarzam M
J Cell Physiol; 2020 Jul; 235(7-8):5835-5846. PubMed ID: 31970786
[TBL] [Abstract][Full Text] [Related]
2. Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment.
Brohée L; Demine S; Willems J; Arnould T; Colige AC; Deroanne CF
Oncotarget; 2015 May; 6(13):11264-80. PubMed ID: 25834103
[TBL] [Abstract][Full Text] [Related]
3. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
Zhou Y; Niu W; Luo Y; Li H; Xie Y; Wang H; Liu Y; Fan S; Li Z; Xiong W; Li X; Ren C; Tan M; Li G; Zhou M
Cancer Sci; 2019 Mar; 110(3):939-949. PubMed ID: 30618169
[TBL] [Abstract][Full Text] [Related]
4. Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy.
Song L; Liu Z; Hu HH; Yang Y; Li TY; Lin ZZ; Ye J; Chen J; Huang X; Liu DT; Zhou J; Shi Y; Zhao H; Xie C; Chen L; Song E; Lin SY; Lin SC
Nat Commun; 2020 Nov; 11(1):5842. PubMed ID: 33203880
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of long-chain acyl-coenzyme A synthetase 4 (ACSL4) expression in human breast cancer.
Dinarvand N; Khanahmad H; Hakimian SM; Sheikhi A; Rashidi B; Pourfarzam M
Res Pharm Sci; 2020 Feb; 15(1):48-56. PubMed ID: 32180816
[TBL] [Abstract][Full Text] [Related]
6. Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival.
He J; Zhang F; Tay LWR; Boroda S; Nian W; Levental KR; Levental I; Harris TE; Chang JT; Du G
FASEB J; 2017 Jul; 31(7):2893-2904. PubMed ID: 28347999
[TBL] [Abstract][Full Text] [Related]
7. Pattern of nucleotide variants of TP53 and their correlation with the expression of p53 and its downstream proteins in a Sri Lankan cohort of breast and colorectal cancer patients.
Manoharan V; Karunanayake EH; Tennekoon KH; De Silva S; Imthikab AIA; De Silva K; Angunawela P; Vishwakula S; Lunec J
BMC Cancer; 2020 Jan; 20(1):72. PubMed ID: 32000721
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.
Tao K; Guo S; Chen R; Yang C; Jian L; Yu H; Liu S
Mol Diagn Ther; 2019 Feb; 23(1):127-138. PubMed ID: 30694446
[TBL] [Abstract][Full Text] [Related]
9. HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration.
Liu C; Li L; Hou G; Lu Y; Gao M; Zhang L
Life Sci; 2022 Aug; 303():120692. PubMed ID: 35671810
[TBL] [Abstract][Full Text] [Related]
10. SHISA3, an antagonist of the Wnt/β-catenin signaling, is epigenetically silenced and its ectopic expression suppresses growth in breast cancer.
Shahzad N; Munir T; Javed M; Tasneem F; Aslam B; Ali M; Mutahir Z; Akhtar Ali M; Umer M; Ahmad M; Farooq K; Hassan U; Mustafa T; Anjum RS; Shakoori AR
PLoS One; 2020; 15(7):e0236192. PubMed ID: 32692756
[TBL] [Abstract][Full Text] [Related]
11. microRNA-214 enhances the invasion ability of breast cancer cells by targeting p53.
Wang F; Lv P; Liu X; Zhu M; Qiu X
Int J Mol Med; 2015 May; 35(5):1395-402. PubMed ID: 25738546
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
13. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
[TBL] [Abstract][Full Text] [Related]
14. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
Sun L; Li Y; Yang B
Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
Aiderus A; Black MA; Dunbier AK
BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
[TBL] [Abstract][Full Text] [Related]
16. Identification of lipidomic profiles associated with drug-resistant prostate cancer cells.
Ingram LM; Finnerty MC; Mansoura M; Chou CW; Cummings BS
Lipids Health Dis; 2021 Feb; 20(1):15. PubMed ID: 33596934
[TBL] [Abstract][Full Text] [Related]
17. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer.
Wang Y; Zhang C; Mai L; Niu Y; Wang Y; Bu Y
BMB Rep; 2019 Feb; 52(2):157-162. PubMed ID: 30760381
[TBL] [Abstract][Full Text] [Related]
18. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
20. KIF15 contributes to cell proliferation and migration in breast cancer.
Gao X; Zhu L; Lu X; Wang Y; Li R; Jiang G
Hum Cell; 2020 Oct; 33(4):1218-1228. PubMed ID: 32578050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
